Ticlopidine Treatment Reduces the Progression of Nonproliferative Diabetic Retinopathy

The Role of Biofactors in Diabetic Microvascular Complications

“…Possible positive effects on DR were described for RAS inhibitors (ACE inhibitors and AT2-receptor blockers) [ 174 - 177 ] and fenofibrate [ 178 , 179 ], but these drugs are not registered for this specific indication. Aspirin may be protective only in very mild DR [ 180 , 181 ] and does not increase the risk of bleeding in PDR [ 182 ].…”

The Role of Biofactors in Diabetic Microvascular Complications

“…Possible positive effects on DR were described for RAS inhibitors (ACE inhibitors and AT2-receptor blockers) [ 174 - 177 ] and fenofibrate [ 178 , 179 ], but these drugs are not registered for this specific indication. Aspirin may be protective only in very mild DR [ 180 , 181 ] and does not increase the risk of bleeding in PDR [ 182 ].…”

The Role of Biofactors in Diabetic Microvascular Complications

“…Possible positive effects on DR were described for RAS inhibitors (ACE inhibitors and AT2-receptor blockers) [ 174 - 177 ] and fenofibrate [ 178 , 179 ], but these drugs are not registered for this specific indication. Aspirin may be protective only in very mild DR [ 180 , 181 ] and does not increase the risk of bleeding in PDR [ 182 ].…”

The Role of Biofactors in Diabetic Microvascular Complications

“…Possible positive effects on DR were described for RAS inhibitors (ACE inhibitors and AT2-receptor blockers) [ 174 - 177 ] and fenofibrate [ 178 , 179 ], but these drugs are not registered for this specific indication. Aspirin may be protective only in very mild DR [ 180 , 181 ] and does not increase the risk of bleeding in PDR [ 182 ].…”